|
Under the efforts of Dr. Gu Xiangyong, Dr. Li Yuxu, Dr. Wang Peng and researcher Du Qiangqiang from Suzhou Pengxu PharmaTech Co., Ltd., the development of a new synthetic technology targeting the new anticancer drug ¡°Irutinib¡± has been completed and Published a general review in the Journal of Chinese Medicinal Chemistry. For details, please refer to Chinese Journal of Medicinal Chemistry 2018, v.28; No. 143(03) 245-252 | |